Efficacy and safety of continuous hemodiafiltration for acute decompensated heart failure

International Heart Journal

Volumn 51, Issue 4, 2010, Pages 247-251

  Shiomi, Hiroki ^a   Matsubara, Kinya ^a   Ariyoshi, Makoto ^a   Iwamura, Yumi ^a   Fukui, Kensuke ^a   Sakamoto, Tomoko ^a   Sawanishi, Takayoshi ^a   Shima, Masami ^a   Furukawa, Keizo ^a  

^a KYOTO CITY HOSPITAL   (Japan)

Author keywords

Cardiogenic shock; CHDF; Heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE HEART FAILURE; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE OVERLOAD; HOSPITAL ADMISSION; HUMAN; HYPERVOLEMIA; JAPAN; MALE; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; RELIABILITY; TREATMENT RESPONSE; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HEART FAILURE; HEMODIAFILTRATION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 77955834371     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.247     Document Type: Article

References (18)

1. Kawashiro N, Kasanuki H, Ogawa H, et al. Clinical characteristics and outcome of hospitalized patients with congestive heart failure: results of the HIJC-HF registry. Circ J 2008; 72: 2015-2020.
2. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002; 13:1928-1936.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
4. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671-678.
5. Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001; 96: 132-143.
6. Costanzo MR. Ultrafiltration in the management of heart failure. Curr Opin Crit Care 2008; 14: 524-530. (Review)
7. Canaud B, Cristol JP, Klouche K, et al. Slow continuous ultrafiltration: a means of unmasking myocardial functional reserve in end stage cardiac disease. Contrib Nephrol 1991; 93: 79-85.
8. Nakanishi K, Hirasawa H, Sugai T, et al. Efficacy of continuous hemodiafiltration for patients with congestive heart failure. Blood Purif 2002; 20: 342-348.
9. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-216.
10. Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683.
11. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P. Early ultrafiltration in patients with acute decompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005; 46: 2047-2051.
12. Rogers HL, Marshall J, Bock J, et al. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Cardiac Fail 2008; 14: 1-5.
13. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001; 103: 2055-2059.
14. Ruiz-Bailén M, Rucabado-Aguilar L, Expósito-Ruiz M, et al. Cardiogenic shock in acute coronary syndrome. Med Sci Monit 2009; 15: RA57-RA66. (Review)
15. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med 1999; 131: 47-59. (Review)
16. Sanborn TA, Feldman T. Management strategies for cardiogenic shock. Curr Opin Cardiol 2004; 19: 608-612. (Review)
17. Zannad F, Adamopoulos C, Mebazaa A, Gheorghiade M. The challenge of acute decompensated heart failure. Heart Fail Rev 2006; 11: 135-119. (Review)
18. Zannad F, Mebazaa A, Juillière Y, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 2006; 8: 697-705.